|
Stroke predition - Inclusion of people with history of stroke
|
|
7
|
330
|
October 31, 2024
|
|
RMS Ordinal Logistic Regression
|
|
54
|
16481
|
October 30, 2024
|
|
Presenting data for extremely small n size clinical trials
|
|
2
|
312
|
October 27, 2024
|
|
Should I bootstrap Spline term construction?
|
|
10
|
409
|
October 22, 2024
|
|
R vs. Python in academia
|
|
9
|
546
|
October 22, 2024
|
|
Estimating totals at group level
|
|
2
|
302
|
October 22, 2024
|
|
Prior design in a bayesian re-analysis of an RCT
|
|
4
|
847
|
October 20, 2024
|
|
Is it a good idea to use two estimators for multilevel meta-regression?
|
|
0
|
180
|
October 19, 2024
|
|
RMS Discussions
|
|
357
|
86142
|
October 17, 2024
|
|
Randomized non-comparative trials: an oxymoron?
|
|
16
|
1396
|
October 15, 2024
|
|
Statistically Efficient Ways to Quantify Added Predictive Value of New Measurements
|
|
79
|
20208
|
October 14, 2024
|
|
Some thoughts on uniform prior probabilities when estimating P values and confidence intervals
|
|
43
|
3541
|
October 12, 2024
|
|
Randomized trial with variation around pre-specified follow-up times
|
|
5
|
2252
|
October 10, 2024
|
|
Trying variable clustering followed by PC1 scoring
|
|
3
|
398
|
October 7, 2024
|
|
RMS Case Study in Cox Regression
|
|
4
|
16127
|
September 28, 2024
|
|
Bayesian Regression Modeling Strategies
|
|
94
|
10100
|
September 23, 2024
|
|
Equipoise lost in RCTs - dropout at random assignment
|
|
5
|
324
|
September 23, 2024
|
|
Why not use the inverse logit transformation to get fitted risks (probabilities) in epi?
|
|
16
|
8173
|
September 21, 2024
|
|
Dynamic regression for survival analysis
|
|
0
|
362
|
September 18, 2024
|
|
AUC for different decision thresholds in an ordinal model
|
|
2
|
364
|
September 17, 2024
|
|
Interpreting the coefficient of a log transformed dependent variable
|
|
2
|
497
|
September 11, 2024
|
|
Bayes for Medical Quality Improvement Analysis
|
|
2
|
429
|
September 10, 2024
|
|
Sensitivity analysis
|
|
0
|
317
|
September 10, 2024
|
|
Improving the model recalibration
|
|
3
|
490
|
September 6, 2024
|
|
Percent change in bone mineral density (BMD) as a surrogate endpoint for fractures
|
|
6
|
2950
|
September 3, 2024
|
|
Learning how to conduct and design meaningful clinical trials
|
|
8
|
680
|
September 3, 2024
|
|
How do we count number of variables to compile with the 15:1 EVP rule?
|
|
4
|
524
|
September 3, 2024
|
|
Causal inferences from RCTs- could “toy” clinical examples promote understanding?
|
|
13
|
841
|
September 2, 2024
|
|
Non-collapsibility of standardized rate
|
|
14
|
594
|
August 31, 2024
|
|
Sample Size in crossover trials
|
|
4
|
587
|
August 29, 2024
|